Ampio initiates pivotal Ampion osteoarthritis trial

Ampio initiates pivotal Ampion osteoarthritis trial

ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE MKT: AMPE) announced it has begun a single injection study to meet the unmet medical need of treating the severe pain and loss of function... Read More

Monday May 1, 2017 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, Dr. David Bar-Or, Chris Ehrlich, Michael Macaluso

Ampio: FDA discussions continue on best path forward for Ampion

Ampio: FDA discussions continue on best path forward for Ampion

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced it is continuing discussions with the CBER Division of the FDA to determine the best path forward to obtain a Biological... Read More

Thursday November 10, 2016 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, Michael Macaluso, FDA

Ampio Pharmaceuticals announces stock sale to investor to raise $3.75M

Ampio Pharmaceuticals announces stock sale to investor to raise $3.75M

ENGLEWOOD -- Ampio Pharmaceuticals , Inc. (NYSE MKT: AMPE) announced it has entered into a securities purchase agreement with an institutional investor providing for the registered sale of... Read More

Thursday September 1, 2016 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion